Insufficient scRNA-seq data for expression of WNT1 at single-cell level.
Insufficient scRNA-seq data for expression of WNT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| spleen | 100% | 39.40 | 240 / 241 | 0% | 0 | 0 / 0 |
| lung | 83% | 11.93 | 479 / 578 | 5% | 0.26 | 61 / 1155 |
| peripheral blood | 77% | 19.69 | 719 / 929 | 0% | 0 | 0 / 0 |
| brain | 67% | 58.10 | 1758 / 2642 | 5% | 0.12 | 38 / 705 |
| stomach | 62% | 7.53 | 221 / 359 | 3% | 0.08 | 9 / 286 |
| thymus | 61% | 7.57 | 399 / 653 | 3% | 0.04 | 17 / 605 |
| prostate | 62% | 6.89 | 152 / 245 | 0% | 0.01 | 2 / 502 |
| intestine | 52% | 15.23 | 502 / 966 | 2% | 0.08 | 13 / 527 |
| bladder | 48% | 6.71 | 10 / 21 | 1% | 0.04 | 6 / 504 |
| breast | 47% | 5.30 | 214 / 459 | 1% | 0.02 | 14 / 1118 |
| adipose | 47% | 4.82 | 565 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 0.79 | 13 / 29 |
| esophagus | 30% | 2.63 | 430 / 1445 | 7% | 0.27 | 12 / 183 |
| uterus | 25% | 1.96 | 43 / 170 | 7% | 0.17 | 33 / 459 |
| kidney | 30% | 4.02 | 27 / 89 | 2% | 0.03 | 17 / 901 |
| blood vessel | 23% | 2.44 | 311 / 1335 | 0% | 0 | 0 / 0 |
| heart | 22% | 2.22 | 190 / 861 | 0% | 0 | 0 / 0 |
| skin | 18% | 1.39 | 328 / 1809 | 3% | 0.08 | 15 / 472 |
| liver | 19% | 1.56 | 44 / 226 | 2% | 0.30 | 7 / 406 |
| adrenal gland | 15% | 1.08 | 39 / 258 | 2% | 0.71 | 5 / 230 |
| ovary | 16% | 2.24 | 28 / 180 | 1% | 0.03 | 3 / 430 |
| pancreas | 13% | 0.86 | 42 / 328 | 3% | 0.04 | 6 / 178 |
| muscle | 5% | 0.36 | 37 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.17 | 2 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
| GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
| GO_0021527 | Biological process | spinal cord association neuron differentiation |
| GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
| GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
| GO_0045444 | Biological process | fat cell differentiation |
| GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
| GO_1904948 | Biological process | midbrain dopaminergic neuron differentiation |
| GO_1902035 | Biological process | positive regulation of hematopoietic stem cell proliferation |
| GO_0030901 | Biological process | midbrain development |
| GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
| GO_0045599 | Biological process | negative regulation of fat cell differentiation |
| GO_1990403 | Biological process | embryonic brain development |
| GO_0021536 | Biological process | diencephalon development |
| GO_0031100 | Biological process | animal organ regeneration |
| GO_0061184 | Biological process | positive regulation of dermatome development |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
| GO_0071425 | Biological process | hematopoietic stem cell proliferation |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0060070 | Biological process | canonical Wnt signaling pathway |
| GO_0021588 | Biological process | cerebellum formation |
| GO_0033077 | Biological process | T cell differentiation in thymus |
| GO_0030182 | Biological process | neuron differentiation |
| GO_0045165 | Biological process | cell fate commitment |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0048664 | Biological process | neuron fate determination |
| GO_0033278 | Biological process | cell proliferation in midbrain |
| GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
| GO_0043568 | Biological process | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO_0022004 | Biological process | midbrain-hindbrain boundary maturation during brain development |
| GO_0060061 | Biological process | Spemann organizer formation |
| GO_0000578 | Biological process | embryonic axis specification |
| GO_0042472 | Biological process | inner ear morphogenesis |
| GO_0036520 | Biological process | astrocyte-dopaminergic neuron signaling |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0021797 | Biological process | forebrain anterior/posterior pattern specification |
| GO_0016055 | Biological process | Wnt signaling pathway |
| GO_0007520 | Biological process | myoblast fusion |
| GO_0060348 | Biological process | bone development |
| GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
| GO_0021551 | Biological process | central nervous system morphogenesis |
| GO_0070365 | Biological process | hepatocyte differentiation |
| GO_0009611 | Biological process | response to wounding |
| GO_0042770 | Biological process | signal transduction in response to DNA damage |
| GO_0010812 | Biological process | negative regulation of cell-substrate adhesion |
| GO_2000773 | Biological process | negative regulation of cellular senescence |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0022408 | Biological process | negative regulation of cell-cell adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030666 | Cellular component | endocytic vesicle membrane |
| GO_0005796 | Cellular component | Golgi lumen |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0009986 | Cellular component | cell surface |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0048018 | Molecular function | receptor ligand activity |
| GO_0005109 | Molecular function | frizzled binding |
| GO_0016015 | Molecular function | morphogen activity |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | WNT1 |
| Protein name | Proto-oncogene Wnt-1 (Proto-oncogene Int-1 homolog) |
| Synonyms | INT1 |
| Description | FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Acts in the canonical Wnt signaling pathway by promoting beta-catenin-dependent transcriptional activation . In some developmental processes, is also a ligand for the coreceptor RYK, thus triggering Wnt signaling (By similarity). Plays an essential role in the development of the embryonic brain and central nervous system (CNS) (By similarity). Has a role in osteoblast function, bone development and bone homeostasis . . |
| Accessions | ENST00000293549.4 P04628 |